Skip to main content
Top
Published in: Journal of Cancer Education 4/2020

01-08-2020

Cancer Awareness and Barriers to Medical Treatment Among Syrian Refugees and Lebanese Citizens in Lebanon

Authors: Jude Alawa, Omar Hamade, Amin Alayleh, Luna Fayad, Kaveh Khoshnood

Published in: Journal of Cancer Education | Issue 4/2020

Login to get access

Abstract

The Syrian conflict has forced over a million refugees into Lebanon, which now faces the challenge of providing healthcare for this large, vulnerable population. Syrian refugees and Lebanese citizens suffer from an immense burden of cancer and encounter many barriers to obtaining healthcare. An increase in cancer awareness could prompt earlier diagnosis and treatment. This study aims to evaluate the level of cancer awareness and barriers to medical treatment among Syrian refugees and Lebanese citizens in Lebanon. A descriptive cross-sectional survey design was used. Four hundred seventeen Syrian refugees and 319 Lebanese citizens seeking healthcare in Lebanon completed the Cancer Awareness Measure. The mean age of Syrian refugees and Lebanese citizens was 33.8 years (SD 11.9) and 41.7 years (SD 16.3), respectively. Syrian refugees and Lebanese citizens were only able to recognize a low number of cancer symptoms (mean 4.2 (out of 9), SD 2.4 and 3.9, SD 2.3, respectively) and risk factors (mean 5.1 (out of 11), SD 2.6 and 5.2, SD 2.9, respectively). Barriers to seeking medical care were prevalent. The most commonly reported barrier among both samples was having no medical insurance or funds to cover the cost of treatment (78.9% and 67.7%, respectively). A comprehensive restructuring of the Lebanese healthcare system and a massive influx of resources are required for Syrian refugees and Lebanese citizens to obtain adequate access to cancer treatment. To encourage early diagnosis and treatment, much more work is needed to overcome barriers and enhance knowledge of cancer.
Literature
1.
go back to reference Ahmad MM (2015) Knowledge and beliefs about cancer prevention and care in Jordan. IOSRD Int J Med 1(1):1–5 Ahmad MM (2015) Knowledge and beliefs about cancer prevention and care in Jordan. IOSRD Int J Med 1(1):1–5
14.
go back to reference Salim EI, Moore MA, Al-Lawati JA, Al-Sayyad J, Bazawir A, Bener A et al (2009) Cancer epidemiology and control in the Arab world-past, present and future. Asian Pac J Cancer Prev 10(1):3–16PubMed Salim EI, Moore MA, Al-Lawati JA, Al-Sayyad J, Bazawir A, Bener A et al (2009) Cancer epidemiology and control in the Arab world-past, present and future. Asian Pac J Cancer Prev 10(1):3–16PubMed
15.
go back to reference Shahraz S, Forouzanfar MH, Sepanlou SG, Dicker D, Naghavi P, Pourmalek F et al (2014) Population health and burden of disease profile of Iran among 20 countries in the region: from Afghanistan to Qatar and Lebanon. Arch Iran Med 17(5):336–342PubMed Shahraz S, Forouzanfar MH, Sepanlou SG, Dicker D, Naghavi P, Pourmalek F et al (2014) Population health and burden of disease profile of Iran among 20 countries in the region: from Afghanistan to Qatar and Lebanon. Arch Iran Med 17(5):336–342PubMed
17.
go back to reference Smith LK, Pope C, Botha JL (2005) Patients’ help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 366(9488):825–831CrossRef Smith LK, Pope C, Botha JL (2005) Patients’ help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 366(9488):825–831CrossRef
20.
go back to reference UNHCR (2017) Vulnerability assessment of Syrian refugees in Lebanon. United Nations High Commissioner for Refugees, Geneva UNHCR (2017) Vulnerability assessment of Syrian refugees in Lebanon. United Nations High Commissioner for Refugees, Geneva
Metadata
Title
Cancer Awareness and Barriers to Medical Treatment Among Syrian Refugees and Lebanese Citizens in Lebanon
Authors
Jude Alawa
Omar Hamade
Amin Alayleh
Luna Fayad
Kaveh Khoshnood
Publication date
01-08-2020
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 4/2020
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-019-01516-3

Other articles of this Issue 4/2020

Journal of Cancer Education 4/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine